304 related articles for article (PubMed ID: 27555294)
21. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
[TBL] [Abstract][Full Text] [Related]
22. Acute pancreatitis in children with acute lymphoblastic leukemia correlates with L-asparaginase dose intensity.
Chen CB; Chang HH; Chou SW; Yang YL; Lu MY; Jou ST; Chen HL; Ni YH; Lin DT; Chang MH; Wu JF
Pediatr Res; 2022 Aug; 92(2):459-465. PubMed ID: 34718353
[TBL] [Abstract][Full Text] [Related]
23. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Parsons SK; Skapek SX; Neufeld EJ; Kuhlman C; Young ML; Donnelly M; Brunzell JD; Otvos JD; Sallan SE; Rifai N
Blood; 1997 Mar; 89(6):1886-95. PubMed ID: 9058708
[TBL] [Abstract][Full Text] [Related]
24. [Minimal contribution of severe hypertriglyceridemia in L-asparaginase-associated pancreatitis developed in a child with acute lymphocytic leukemia].
Goto Y; Nishimura R; Nohara A; Mase S; Fujiki T; Irabu H; Kuroda R; Araki R; Ikawa Y; Maeba H; Yachie A
Rinsho Ketsueki; 2016 Aug; 57(8):994-8. PubMed ID: 27599414
[TBL] [Abstract][Full Text] [Related]
25. The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia.
Tong WH; Pieters R; de Groot-Kruseman HA; Hop WC; Boos J; Tissing WJ; van der Sluis IM
Haematologica; 2014 Nov; 99(11):1716-21. PubMed ID: 25150254
[TBL] [Abstract][Full Text] [Related]
26. Acid-suppressing Drugs and a Low 1 Level of Antithrombin as Risk Factors for L-Asparaginase-associated Pancreatitis: A Case-control Study in the Japan Association of Childhood Leukemia Study (JACLS).
Hashii Y; Yoshida M; Hara J; Nishimura S; Yumura-Yagi K; Horibe K; Nakahata T
J Pediatr Hematol Oncol; 2018 Jul; 40(5):374-378. PubMed ID: 29697579
[TBL] [Abstract][Full Text] [Related]
27. Relationship between modified CT severity index and clinical features of L-asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia.
Oh HJ; Im SA; Lee JW; Chung NG; Cho B
Pediatr Hematol Oncol; 2014 Oct; 31(7):647-55. PubMed ID: 24933500
[TBL] [Abstract][Full Text] [Related]
28. Risk Factors for Asparaginase-associated Pancreatitis: A Systematic Review.
Oparaji JA; Rose F; Okafor D; Howard A; Turner RL; Orabi AI; Byersdorfer C; Mi Q; Ritchey K; Lowe ME; Husain SZ
J Clin Gastroenterol; 2017; 51(10):907-913. PubMed ID: 28375864
[TBL] [Abstract][Full Text] [Related]
29. Severe drug-induced hypertriglyceridemia treated with plasmapheresis in children with acute lymphoblastic leukemia.
Zawitkowska J; Lejman M; Zaucha-Prażmo A; Sekuła N; Greczkowska-Chmiel T; Drabko K
Transfus Apher Sci; 2019 Oct; 58(5):634-637. PubMed ID: 31515171
[TBL] [Abstract][Full Text] [Related]
30. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
31. Successful Management of l-Asparaginase-Associated Pancreatitis With Octreotide and Pegylated Asparaginase in 2 Patients With Acute Lymphoblastic Leukemia: Is There a Different Rare Warning Sign of Hypoglycemia for l-Asparaginase-Associated Pancreatitis?
Aydin Köker S; Oymak Y; Demirağ B; Karapinar TH; Koker A; Genç S; Erdemir G; Vergin RC
Clin Ther; 2020 Apr; 42(4):e82-e86. PubMed ID: 32184014
[TBL] [Abstract][Full Text] [Related]
32. Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol.
Wang J; Jia WG; Yang LH; Kuang WY; Huang LB; Chen HQ; Wang LN; Zhou DH; Liao N
Hematology; 2023 Dec; 28(1):2171723. PubMed ID: 36752506
[TBL] [Abstract][Full Text] [Related]
33. Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma.
Tozuka M; Yamauchi K; Hidaka H; Nakabayashi T; Okumura N; Katsuyama T
Ann Clin Lab Sci; 1997; 27(5):351-7. PubMed ID: 9303174
[TBL] [Abstract][Full Text] [Related]
34. Asparaginase-associated pancreatitis in children.
Raja RA; Schmiegelow K; Frandsen TL
Br J Haematol; 2012 Oct; 159(1):18-27. PubMed ID: 22909259
[TBL] [Abstract][Full Text] [Related]
35. Insulin-dependent diabetes: A chronic complication to acute pancreatitis in childhood acute lymphoblastic leukemia.
Wolthers BO; Mogensen PR; Frandsen TL; Abrahamsson J; Behrendtz M; Heyman M; Lohi O; Norén-Nyström U; Ruud E; Schmiegelow K
Pediatr Blood Cancer; 2019 Jan; 66(1):e27437. PubMed ID: 30216644
[TBL] [Abstract][Full Text] [Related]
36. The Characteristics and Risk Factors of Asparaginase-Associated Pancreatitis in Pediatric Acute Lymphoblastic Leukemia.
Kuo SH; Chen JS; Cheng CN; Lo HY; Chen WC; Lai FP; Yang YJ
Pancreas; 2022 Apr; 51(4):366-371. PubMed ID: 35695827
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia.
Chiewchengchol D; Wananukul S; Noppakun N
Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405
[TBL] [Abstract][Full Text] [Related]
38. Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis.
Kearney SL; Dahlberg SE; Levy DE; Voss SD; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2009 Aug; 53(2):162-7. PubMed ID: 19405141
[TBL] [Abstract][Full Text] [Related]
39. Can Machine Learning Models Predict Asparaginase-associated Pancreatitis in Childhood Acute Lymphoblastic Leukemia.
Nielsen RL; Wolthers BO; Helenius M; Albertsen BK; Clemmensen L; Nielsen K; Kanerva J; Niinimäki R; Frandsen TL; Attarbaschi A; Barzilai S; Colombini A; Escherich G; Aytan-Aktug D; Liu HC; Möricke A; Samarasinghe S; van der Sluis IM; Stanulla M; Tulstrup M; Yadav R; Zapotocka E; Schmiegelow K; Gupta R
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e628-e636. PubMed ID: 35226426
[TBL] [Abstract][Full Text] [Related]
40. Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation.
Tram Henriksen L; Gottschalk Højfeldt S; Schmiegelow K; Frandsen TL; Skov Wehner P; Schrøder H; Klug Albertsen B;
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28660740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]